936755-53-2

Upstream product

• 936755-51-0 methyl 4-(1,1-difluoro-2-methoxy-2-oxoethyl)benzoate 
• 52812-74-5 dimethyl ester of 1,4-benzenemonoketodicarboxylic acid 
• 6051-67-8 1,4-benzenemonoketodicarboxylic acid 
• 302912-31-8 ethyl-4-cyanobenzoylformate 
• 936755-52-1 2,2-difluoro-2-(4-(methoxycarbonyl)phenyl)acetic acid 
• 7466-54-8 2-methoxybenzoylhydrazine 

Downstream Products

• 936755-54-3 4-{1,1-difluoro-2-[2-(2-methoxybenzoyl)hydrazino]-2-oxoethyl}benzoic acid 
• 936755-55-4 tert-butyl {3-[(4-{1,1-difluoro-2-[2-(2-methoxybenzoyl)hydrazino]-2-oxoethyl}benzoyl)amino]-1-phenyl-1H-pyrazol-4-yl} carbamate 
• 936755-56-5 tert-butyl {3-[(4-{difluoro[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl}benzoyl)amino]-1-phenyl-1H-pyrazol-4-yl} carbamate 

Relevant academic research and scientific papers

HISTONE DEACETYLASE INHIBITORS WITH ARYL-PYRAZOLYL MOTIFS

The present invention relates to a novel class of histone deacetylase inhibitors with aryl-pyrazolyl motifs. The compounds of this invention can be used to treat cancer. The compounds of this invention are suitable for use in selectively inducing terminal

FLUORINATED ARYLAMIDE DERIVATIVES

The present invention relates to a novel class of fluorinated arylamide derivatives. The instant compounds can be used to treat cancer. The fluorinated arylamide derivatives can also inhibit histone deacetylase and are suitable for use in selectively indu